Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Intrabio Ltd. has 3 pending office actions in Biotechnology & Pharmaceuticals. The actions are spread among 3 distinct examiners and 3 distinct art units, showing that the portfolio is divided across separate examination assignments.
SEITZ, ANTHONY JOSEPH is the busiest examiner, with 1 pending matter. Matter-specific analysis will be important because no single examiner or art unit covers the pending work.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEITZ, ANTHONY JOSEPH | 1 | 67.8% | +27.5% |
| WELLS, LAUREN QUINLAN | 1 | 49.4% | +59.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18921779 | DEUTERATED ANALOGS OF ACETYL-LEUCINE | SEITZ, ANTHONY JOSEPH | — |
| 17999598 | THE COMBINATION OF ACETYL LEUCINE AND 4-AMINOPYRIDINE OR ACETAZOLAMIDE FOR TREATING ATAXIA | WELLS, LAUREN QUINLAN | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18921779 | DEUTERATED ANALOGS OF ACETYL-LEUCINE | SEITZ, ANTHONY JOSEPH | 1629 | DP | Non-Final OA | — | Pending | Oct 21, 2024 |
| 17999598 | THE COMBINATION OF ACETYL LEUCINE AND 4-AMINOPYRIDINE OR ACETAZOLAMIDE FOR TREATING ATAXIA | WELLS, LAUREN QUINLAN | 1622 | §103 | Final Rejection | — | Pending | Nov 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIntrabio Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Anthony Joseph Seitz has the most, with 1 of Intrabio Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
